The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector easily access and use already available SIAPS resources, including tools, experiences, and results. The document is also intended to serve as a technical legacy for SIAPS to support knowledge exchange and sustainability of related work. … Read more
SIAPS final report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs.
The US Ambassador to Namibia, H.E. Thomas F. Daughton, launched CBART group ARV refills on June 1, 2017. These groups are implemented widely in Onandjokwe and other districts in northern Namibia, where the HIV burden is high. During the CBART group ARV refill initiative launch, the ambassador remarked “simple solutions = best solutions; bring the … Read more
SIAPS Final Report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs. [button style=”download” link=”https://siapsprogram.org/wp-content/uploads/2018/03/SIAPS-End-of-Program-Report.pdf” color=”silver”]Download this file as a PDF[/button]
On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program. More than 100 attendees gathered in Arlington, VA, to discuss progress made and opportunities toward ensuring that quality, life-saving essential medicines and services are available and affordable for the world’s poorest and … Read more
This infographic provides an overview of select SIAPS interventions and results in line with six core health system functions: governance; capacity building; information for decision-making; financing; supply chain; and pharmaceutical services.
The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to essential health service agenda and definitively recognized the critical role of medicines in achieving UHC. The SDGs call for countries to “achieve universal health coverage, including financial risk protection, access to quality essential health care … Read more
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats —one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and … Read more
